ResearcherColumbia UniversityActive in the last 2 years
Marie C. Hasselluhn
Matched on ORCID iD 0000-0001-9765-4075; OpenAlex author ID A5083270280; NIH RePORTER profile ID 78341921. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 1, last author 0)
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 64
2016: 1 paper · 2017: none · 2018: none · 2019: 3 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 6 papers · 2025: none · 2026: 2 papers, 1 grant
Papers 12
- Pancreatic ductal adenocarcinoma: The Vision of Heracles. Co-author DOI 10.1016/j.ccell.2026.07.014↗
- Continuous tissue fields organize immune composition in pancreatic cancer Co-author DOI 10.64898/2026.08.22.746444↗
- Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Co-author DOI 10.1038/s41586-024-07379-z↗
- Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08084-7↗
- An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. Co-author DOI 10.1053/j.gastro.2023.10.026↗
- “Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug” Co-author DOI 10.1101/2024.05.02.592216↗
- Pancreatic Cancer-Associated Fibroblasts: Where Do We Go from Here? Co-author DOI 10.1158/0008-5472.can-24-2860↗
- Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. Co-author DOI 10.1158/2159-8290.cd-23-0240↗
- Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression. Co-author DOI 10.1038/s41419-019-1682-2↗
- A tangled tale of molecular subtypes in pancreatic cancer. First author DOI 10.1136/gutjnl-2018-318086↗
- Stromal Features of the Primary Tumor Are Not Prognostic in Genetically Engineered Mice of Pancreatic Cancer. Co-author DOI 10.3390/cells9010058↗
- NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation. Co-author DOI 10.1155/2016/5272498↗
Grants 1
Closest collaborators
The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kenneth P. Olive · 5 shared papers, 2024–2026 · strength 0.94
- Paper Pancreatic Cancer-Associated Fibroblasts: Where Do We Go from Here? DOI 10.1158/0008-5472.can-24-2860↗
- Paper “Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug” DOI 10.1101/2024.05.02.592216↗
- Paper Pancreatic ductal adenocarcinoma: The Vision of Heracles. DOI 10.1016/j.ccell.2026.07.014↗
- Mara H. Sherman · 2 shared papers, 2024–2026 · strength 0.50
- Marina Pasca di Magliano · 2 shared papers, 2024–2026 · strength 0.42
- Anirban Maitra · 2 shared papers, 2024–2026 · strength 0.42
- Volker Ellenrieder · 4 shared papers, 2016–2024 · strength 0.42
- Paper An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. DOI 10.1053/j.gastro.2023.10.026↗
- Paper Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progress… DOI 10.1038/s41419-019-1682-2↗
- Paper Stromal Features of the Primary Tumor Are Not Prognostic in Genetically Engineered Mice of Pancreatic Cancer. DOI 10.3390/cells9010058↗
- Albrecht Neeße · 3 shared papers, 2019–2024 · strength 0.40
- Paper A tangled tale of molecular subtypes in pancreatic cancer. DOI 10.1136/gutjnl-2018-318086↗
- Paper An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. DOI 10.1053/j.gastro.2023.10.026↗
- Paper Stromal Features of the Primary Tumor Are Not Prognostic in Genetically Engineered Mice of Pancreatic Cancer. DOI 10.3390/cells9010058↗
- Amanda R. Decker-Farrell · 2 shared papers, 2024 · strength 0.38
- Elisabeth Heßmann · 3 shared papers, 2016–2024 · strength 0.32
- Paper An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. DOI 10.1053/j.gastro.2023.10.026↗
- Paper Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progress… DOI 10.1038/s41419-019-1682-2↗
- Paper NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation. DOI 10.1155/2016/5272498↗
- Shiv K. Singh · 2 shared papers, 2019–2024 · strength 0.30
- Mikala Egeblad · 1 shared paper, 2026 · strength 0.27
- Weihao Wang · 1 shared paper, 2026 · strength 0.27
- Shayan Sarkar · 1 shared paper, 2026 · strength 0.27
- Lyanne Delgado Coka · 1 shared paper, 2026 · strength 0.27
- Despina Siolas · 1 shared paper, 2026 · strength 0.27
- Luisa F. Escobar‐Hoyos · 1 shared paper, 2026 · strength 0.27
- Kenneth Reed Shroyer · 1 shared paper, 2026 · strength 0.27
- Scott Powers · 1 shared paper, 2026 · strength 0.27
- Steven A. Johnsen · 2 shared papers, 2019–2024 · strength 0.26
- Paper An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. DOI 10.1053/j.gastro.2023.10.026↗
- Paper Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progress… DOI 10.1038/s41419-019-1682-2↗
- Eileen S. Carpenter · 1 shared paper, 2024 · strength 0.23
- Debora Barbosa Vendramini Costa · 1 shared paper, 2024 · strength 0.23
- Edna Cukierman · 1 shared paper, 2024 · strength 0.23
- Michael A. Badgley · 1 shared paper, 2024 · strength 0.22
- Alexander Otto König · 2 shared papers, 2016–2024 · strength 0.19
- Pilhan Kim · 1 shared paper, 2026 · strength 0.19
- Marina Lesina · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.